Revance Therapeutics Inc (RVNC)

Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 11, 2025

Jun 10, 2025

Two Sigma Investments LP Acquires 13,539 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 10, 2025

Jun 08, 2025

Ameriprise Financial Inc. Raises Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 08, 2025

Jun 05, 2025

Investor Network: Revance Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Jun 05, 2025

Jun 04, 2025

BNP Paribas Financial Markets Sells 10,728 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 04, 2025

Jun 02, 2025

Deutsche Bank AG Grows Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 02, 2025

Jun 02, 2025

Jane Street Group LLC Sells 491,504 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 02, 2025

Jun 01, 2025

ProShare Advisors LLC Increases Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Jun 01, 2025

May 31, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Consensus Rating of “Hold” by Brokerages - Defense World

May 31, 2025

May 29, 2025

Millennium Management LLC Increases Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 29, 2025

May 27, 2025

Revance Announces Blue Lizard® Australian Sunscreen Times Square Takeover to Celebrate National Sunscreen Day - The Malaysian Reserve

May 27, 2025

May 26, 2025

The Gross Law Firm Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – RVNC - Louisiana First News

May 26, 2025

May 24, 2025

Northern Trust Corp Has $3.01 Million Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 24, 2025

May 23, 2025

Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at Wall Street Zen - Defense World

May 23, 2025

May 23, 2025

Revance Names New CEO to Drive Next Phase in Aesthetic Innovation - Global Cosmetics News

May 23, 2025

May 22, 2025

Revance Announces Blue Lizard Australian Sunscreen® Partnership with The Bentway for Their Summer 2025 Sun/Shade Program - The Malaysian Reserve

May 22, 2025

May 21, 2025

Revance Announces Leadership Succession Plan to Support Next Phase of Growth and Innovation - Longview News-Journal

May 21, 2025

May 16, 2025

Price T Rowe Associates Inc. MD Purchases 7,839 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 16, 2025

May 14, 2025

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - ACCESS Newswire

May 14, 2025

May 14, 2025

Dermata Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

Revolutionary Once-Weekly Natural Acne Treatment Achieves Breakthrough in Phase 3 Trial Results - Stock Titan

May 14, 2025

May 13, 2025

Revance Therapeutics (NASDAQ:RVNC) Now Covered by StockNews.com - Defense World

May 13, 2025

May 13, 2025

Hsbc Holdings PLC Cuts Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 13, 2025

May 12, 2025

Lost Money on Revance Therapeutics, Inc. (RVNC)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 12, 2025

May 11, 2025

Shareholders that Lost Money on Revance Therapeutics, Inc. (RVNC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 11, 2025

May 10, 2025

Revance Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire

May 10, 2025

May 10, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Acquired by Wells Fargo & Company MN - Defense World

May 10, 2025

May 10, 2025

Revance Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationRVNC - ACCESS Newswire

May 10, 2025

May 09, 2025

MetLife Investment Management LLC Has $184,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 09, 2025

May 09, 2025

Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) PT at $8.39 - Defense World

May 09, 2025

May 05, 2025

Invesco Ltd. Boosts Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 05, 2025

May 05, 2025

Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com - Defense World

May 05, 2025

May 02, 2025

Spasticity Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Jazz Pharmaceuticals, Revance Therapeutics, Ipsen - Barchart.com

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 02, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Sold by LPL Financial LLC - Defense World

May 02, 2025

May 01, 2025

Revance Announces Blue Lizard® Australian Sunscreen Named the #1 Selling Mineral Sunscreen Brand - StreetInsider

May 01, 2025

Apr 27, 2025

Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com - Defense World

Apr 27, 2025

Apr 27, 2025

Levi & Korsinsky Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineRVNC - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Geode Capital Management LLC Raises Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 25, 2025

Apr 24, 2025

Investigation announced for Long-Term Investors in Revance - openPR.com

Apr 24, 2025

Apr 24, 2025

Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com

Apr 24, 2025

Apr 21, 2025

JPMorgan Chase & Co. Sells 2,335,359 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 21, 2025